TickerFacts.

Medpace Holdings, Inc. (MEDP): Operating Income

Annual figures by period end, from SEC filings.

$534.93M
Year ended 2025-12-31
$583.40M
Trailing 12 months to 2026-06-30
+24.3%
3-year compound annual growth
+26.2%
5-year compound annual growth
+38.5%
10-year compound annual growth
2015-12-31: $20.56M2016-12-31: $52.49M2017-12-31: $64.86M2018-12-31: $101.05M2019-12-31: $127.26M2020-12-31: $167.04M2021-12-31: $198.62M2022-12-31: $278.70M2023-12-31: $336.82M2024-12-31: $446.87M2025-12-31: $534.93M$534.93M
2015-12-31 Operating Income (USD) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31$534.93M+19.7%2026-02-10, From 2025-01-01
2024-12-31$446.87M+32.7%2026-02-10, From 2024-01-01
2023-12-31$336.82M+20.9%2026-02-10, From 2023-01-01
2022-12-31$278.70M+40.3%2025-02-11, From 2022-01-01
2021-12-31$198.62M+18.9%2024-02-13, From 2021-01-01
2020-12-31$167.04M+31.3%2023-02-14, From 2020-01-01
2019-12-31$127.26M+25.9%2022-02-15, From 2019-01-01
2018-12-31$101.05M+55.8%2021-02-16, From 2018-01-01
2017-12-31$64.86M+23.6%2020-02-25, From 2017-01-01
2016-12-31$52.49M+155.3%2019-02-26, From 2016-01-01
2015-12-31$20.56Mn/a2018-02-27, From 2015-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
Medpace Holdings, Inc. (MEDP)2025-12-31$534.93M+19.7%
Charles River Laboratories International, Inc. (CRL)2025-12-27$25.16M-88.9%
Incyte Corp (INCY)2025-12-31$1.51Bn/m
Icon PLC (ICLR)2025-12-31$442.85M-57.1%
Iqvia Holdings Inc. (IQV)2025-12-31$2.18B-0.9%
NRC Health (NRC)2025-12-31$22.59M-35.8%
MaxCyte, Inc. (MXCT)2025-12-31-$51.90Mn/m
OmniAb, Inc. (OABI)2025-12-31-$68.97Mn/m
Foxo Technologies Inc. (FOXO)2025-12-31-$10.33Mn/m

Compare MEDP, CRL, INCY, ICLR side by side · Screen every company in Services-Commercial Physical & Biological Research ↗